Prosecution Insights
Last updated: August 18, 2026

Examiner: LUONG, PETER

Tech Center 3700 • Art Units: 3737 3777 3793 3797

This examiner grants 69% of resolved cases

Performance Statistics

69.0%
Allow Rate
-1.0% vs TC avg
771
Total Applications
+27.0%
Interview Lift
1358
Avg Prosecution Days
Based on 732 resolved cases, 2023–2026

Rejection Statute Breakdown

8.3%
§101 Eligibility
18.2%
§102 Novelty
40.7%
§103 Obviousness
24.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18596589 CONTROL APPARATUS, CONTROL METHOD, AND CONTROL PROGRAM Non-Final OA FUJIFILM Corporation
18336918 IMAGE PROCESSING DEVICE, METHOD, AND PROGRAM Final Rejection FUJIFILM Corporation
18713211 ENDOSCOPIC EXAMINATION ASSISTANCE DEVICE, ENDOSCOPIC EXAMINATION ASSISTANCE SYSTEM, ENDOSCOPIC EXAMINATION ASSISTANCE METHOD, AND RECORDING MEDIUM Final Rejection NEC Corporation
19192171 Minimal Catheter Length Tool Non-Final OA Bard Access Systems, Inc.
19002387 ULTRASOUND DETECTION OF CLOTS IN THE BLOODSTREAM Non-Final OA CALIFORNIA INSTITUTE OF TECHNOLOGY
18507663 INTERFEROMETRIC SPECKLE VISIBILITY SPECTROSCOPY Non-Final OA California Institute of Technology
18917640 Methods for Controlling Cooperative Surgical Instruments Final Rejection Cilag GmbH International
18836984 METHOD FOR MOBILE X-RAY ACQUISITION OF A PATIENT Non-Final OA KONINKLIJKE PHILIPS N.V.
19036237 AUTOMATIC CARDIOVASCULAR MAGNETIC RESONANCE IMAGING Non-Final OA The Cleveland Clinic Foundation
19072761 TREATMENT SUPPORT APPARATUS AND IMAGE GENERATION METHOD Non-Final OA SHIMADZU CORPORATION
17635207 TREATMENT SUPPORT APPARATUS AND IMAGE GENERATION METHOD Non-Final OA SHIMADZU CORPORATION
19172037 PLASMA CREATION VIA NONAQUEOUS OPTICAL BREAKDOWN OF LASER PULSE ENERGY FOR BREAKUP OF VASCULAR CALCIUM Non-Final OA Bolt Medical, Inc.
18744824 PROMOTING GENERALIZATION IN CROSS-DATASET REMOTE PHOTOPLETHYSMOGRAPHY Non-Final OA University of Notre Dame du Lac

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month